Gamma-hydroxybutyric acid sedation in neonates and children undergoing MR imaging

Klin Padiatr. 2007 Jul-Aug;219(4):217-9. doi: 10.1055/s-2007-973056.

Abstract

Background: Insufficient sedation in pediatric magnetic resonance imaging (MRI) results in prolonged examination time. To describe the efficacy and side effects of sedation with Phenobarbital short-time infusion followed by continuous gamma-hydroxybutyric acid (GHB) infusion in neonates and children for MRI examinations in a retrospective study.

Patients: With Institutional Review Board approval 94 children (Group I: 1-4 weeks; Group II: >1 to 6 months; Group III: >6 months) were sedated with phenobarbital 10 mg/kg (maximum 200 mg) intravenously 30 min prior to examination. Than intravenous sedation was maintained with GHB 10 mg/kg/h after a priming dose of 30 mg/kg in 20 min.

Results: In group 1 all neonates (n=8) were well sedated without side effect. One of 21 infants in group 2 showed restlessness and the MRI failed. Two of 65 patients of group 3 were not sufficiently sedated and one of them vomited.

Conclusions: Non-invasive diagnostic procedures in neonates and children may be managed by phenobarbital and GHB sedation with side effects or failure of 3%.

MeSH terms

  • Age Factors
  • Anesthetics, Intravenous* / adverse effects
  • Child
  • Child, Preschool
  • Conscious Sedation*
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Magnetic Resonance Imaging*
  • Male
  • Phenobarbital* / adverse effects
  • Retrospective Studies
  • Sodium Oxybate* / adverse effects

Substances

  • Anesthetics, Intravenous
  • Sodium Oxybate
  • Phenobarbital